| Business Name: |
Lim-Meneses Emelita MD |
| Contact Person: |
Emelita Lim-Meneses |
| Address: |
11246 South Michigan Avenue, Chicago, Illinois 60628 |
| Phone Number: |
(630) 935-8857 |
| Annual Revenue (USD): |
$500.000 to $999.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
6211110 |
| Share This Business: |
|
| Related Businesses: |
Marie Brister-Brown Md - Chicago, IL 60628
Shah Ashvin N MD - Chicago, IL 60628
Khan Muhammad Z MD - Chicago, IL 60628
Richardson Lisa MD - Chicago, IL 60628
Searles Ericka MD - Chicago, IL 60628
Cave Rogelio O MD - Chicago, IL 60628
Erythro Medical & Urgent Care - Chicago, IL 60628
Smith Jamiere MD - Chicago, IL 60628
Roseland Neighborhood Hlth Center - Chicago, IL 60628
Heinz Pharmacy Inc - Chicago, IL 60628
Rosanwo Matilda MD - Chicago, IL 60628
Shafi Ahmed MD - Chicago, IL 60628
Clark-White Cordia M MD - Chicago, IL 60628
Saldanha John MD - Chicago, IL 60628
Lca Halsted Physician Group - Chicago, IL 60628
Ekong Edwin MD - Chicago, IL 60628
Jonson Virgilio I MD - Chicago, IL 60628
Sales Remedios MD - Chicago, IL 60628
Lee Young S MD - Chicago, IL 60628
Killingsworth Deborah MD - Chicago, IL 60628
|
The company Lim-Meneses Emelita MD provides B2C services in the form of Doctors from its single location in Illinois.
1 to 4 employees work for Lim-Meneses Emelita MD, and the business now earns $500.000 to $999.999 per annum.
Lim-Meneses Emelita MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Lim-Meneses Emelita MD, please call Emelita Lim-Meneses with the phone number (630) 935-8857 or visit its single location at 11246 South Michigan Avenue in Chicago, Illinois 60628.
The location of the single location can also be found using the coordinates 41.6894,-87.62109.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.